ExodusPoint Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

ExodusPoint Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-36,904	Closed	-$701K	–	1462
2019 Q1	$701K	Buy	36,904 +20,004	+118%	+$325K	0.05%	251
2018 Q4	$228K	Buy	+16,900	New	+$189K	0.02%	240

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

ExodusPoint Capital Management's OSIR Position: Q2 2019 in Review

ExodusPoint Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 36,904 shares — an estimated $701K sold.

ExodusPoint Capital Management first reported a position in OSIR in Q4 2018 and held it in 2 quarters. The position peaked at $701K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

ExodusPoint Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
ExodusPoint Capital Management sold 36,904 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $701K.
ExodusPoint Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
ExodusPoint Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $701K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on ExodusPoint Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.